Hubbard R A, Speidel M T, Marchalonis J J, Cone R E
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston 29425.
Mol Immunol. 1989 May;26(5):447-56. doi: 10.1016/0161-5890(89)90104-1.
The monoclonal murine T cell hybridoma, 51H7D, was previously shown to bind the arsazobenzene hapten and to produce a soluble antigen-binding molecule. In this paper we characterize this antigen-binding immunoprotein for its relationship to known T cell receptors serologically, using antibodies specific for variable region framework, or joining region peptides predicted from gene sequence and by biochemical means. The 51H7D cell expresses a protein with subunit size of approximately 31,000, that reacts antigenically with affinity-purified antibodies directed against synthetic first framework and joining segment peptides, corresponding to the gene sequence of the T cell receptor beta chain, YT35. This molecule does not react with affinity-purified antibodies directed against murine immunoglobulin, framework 1 sequences of alpha and gamma T cell receptors, or with antibodies against synthetic heavy chain joining segments. The subunit of mol. wt. 31,000 can form higher aggregates, notably in the mol. wt range of 60,000-70,000, depending upon extraction conditions. The soluble form of the antigen-binding molecule bears the J beta cross-reactive determinant and occurs predominantly as a charge restricted molecular species of approximate mol. wt 60,000-70,000. The purified molecule has a blocked N-terminus, but quantitative statistical analysis of its amino acid composition indicates a closer relatedness to T cell receptor beta chains and other antigen-binding T cell products, than it has to alpha, gamma or delta TCR chains. No evidence for more than one type of polypeptide chain was found and the polymerization is not dependent upon the formation of disulfide bonds. These studies raise the possibility that antigen-binding soluble T cell molecules might belong to a new family of immunoproteins, that is related to, but distinct from, classical immunoglobulins and alpha beta or gamma delta heterodimers.
单克隆鼠T细胞杂交瘤51H7D先前已被证明可结合偶氮苯砷半抗原并产生可溶性抗原结合分子。在本文中,我们通过血清学方法,使用针对可变区框架或根据基因序列预测的连接区肽段的特异性抗体,并通过生化手段,来表征这种抗原结合免疫蛋白与已知T细胞受体的关系。51H7D细胞表达一种亚基大小约为31,000的蛋白质,该蛋白质与针对合成的第一框架和连接片段肽段的亲和纯化抗体发生抗原反应,这些肽段对应于T细胞受体β链YT35的基因序列。该分子不与针对鼠免疫球蛋白、α和γ T细胞受体的框架1序列的亲和纯化抗体反应,也不与针对合成重链连接片段的抗体反应。分子量为31,000的亚基可形成更高的聚集体,特别是在分子量范围为60,000 - 70,000之间,这取决于提取条件。抗原结合分子的可溶性形式带有Jβ交叉反应决定簇,主要以电荷受限的分子形式存在,分子量约为60,000 - 70,000。纯化的分子具有封闭的N末端,但对其氨基酸组成的定量统计分析表明,它与T细胞受体β链和其他抗原结合T细胞产物的亲缘关系比与α、γ或δ TCR链更近。未发现存在不止一种类型多肽链的证据,并且聚合不依赖于二硫键的形成。这些研究提出了一种可能性,即抗原结合可溶性T细胞分子可能属于一个新的免疫蛋白家族,该家族与经典免疫球蛋白以及αβ或γδ异二聚体相关,但又有所不同。